Medigene
Medigene is a Germany-based biotechnology company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Business Model:
Revenue: $29.5M
Employees: 51-200
Industries / Tags:
Detailed Medigene Information
Geographic Data
Address: Lochhamer Str. 11
City: Martinsried
State: bavaria
Zip: 82152
Country: DE
Financial Info
Stage:
post ipo equity
Raised Last:
$29M
Raised Total:$29M
Social
Metrics
1,949,154Website Global Rank
10,959Website Monthly Traffic
Twitter Followers
Description
Medigene is a Germany-based biotechnology company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
Medigene went public on 6/30/2000 on the Other
Listed Exchange:
Other
IPO Date:
6/30/2000
Ticker Symbol:
MDG1
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2015 | leon nanodrugs | Series A | 0 |
| 7/2015 | leon nanodrugs | Series A | 0 |
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
